» Articles » PMID: 24024159

Upregulation of the Mitochondrial Lon Protease Allows Adaptation to Acute Oxidative Stress but Dysregulation is Associated with Chronic Stress, Disease, and Aging

Overview
Journal Redox Biol
Date 2013 Sep 12
PMID 24024159
Citations 76
Authors
Affiliations
Soon will be listed here.
Abstract

The elimination of oxidatively modified proteins is a crucial process in maintaining cellular homeostasis, especially during stress. Mitochondria are protein-dense, high traffic compartments, whose polypeptides are constantly exposed to superoxide, hydrogen peroxide, and other reactive species, generated by 'electron leakage' from the respiratory chain. The level of oxidative stress to mitochondrial proteins is not constant, but instead varies greatly with numerous metabolic and environmental factors. Oxidized mitochondrial proteins must be removed rapidly (by proteolytic degradation) or they will aggregate, cross-link, and cause toxicity. The Lon Protease is a key enzyme in the degradation of oxidized proteins within the mitochondrial matrix. Under conditions of acute stress Lon is highly inducible, possibly with the oxidant acting as the signal inducer, thereby providing increased protection. It seems that under chronic stress conditions, however, Lon levels actually decline. Lon levels also decline with age and with senescence, and senescent cells even lose the ability to induce Lon during acute stress. We propose that the regulation of Lon is biphasic, in that it is up-regulated during transient stress and down-regulated during chronic stress and aging, and we suggest that the loss of Lon responsiveness may be a significant factor in aging, and in age-related diseases.

Citing Articles

The Interplay between von Hippel-Lindau Tumor Suppressor Gene, Lon Protease, ROS Accumulation, and Inflammation in Clear Cell Renal Cell Carcinoma.

Tsai Y, Kuo C Curr Issues Mol Biol. 2024; 46(10):11296-11302.

PMID: 39451551 PMC: 11506291. DOI: 10.3390/cimb46100671.


Readdressing the Localization of Apolipoprotein E (APOE) in Mitochondria-Associated Endoplasmic Reticulum (ER) Membranes (MAMs): An Investigation of the Hepatic Protein-Protein Interactions of APOE with the Mitochondrial Proteins Lon Protease....

Rueter J, Rimbach G, Bilke S, Tholey A, Huebbe P Int J Mol Sci. 2024; 25(19).

PMID: 39408926 PMC: 11476584. DOI: 10.3390/ijms251910597.


Aging of alveolar type 2 cells induced by deficiency exacerbates pulmonary fibrosis.

Zhu W, Tan C, Zhang J Biomol Biomed. 2024; 24(5):1258-1272.

PMID: 38625722 PMC: 11378998. DOI: 10.17305/bb.2024.10429.


The effect of TLR3 priming conditions on MSC immunosuppressive properties.

Tolstova T, Dotsenko E, Kozhin P, Novikova S, Zgoda V, Rusanov A Stem Cell Res Ther. 2023; 14(1):344.

PMID: 38031182 PMC: 10687850. DOI: 10.1186/s13287-023-03579-y.


IPMK modulates FFA-induced insulin resistance in primary mouse hepatocytes.

Jung I, Ahima R, Kim S bioRxiv. 2023; .

PMID: 37162825 PMC: 10168377. DOI: 10.1101/2023.04.26.538310.


References
1.
Liu T, Lu B, Lee I, Ondrovicova G, Kutejova E, Suzuki C . DNA and RNA binding by the mitochondrial lon protease is regulated by nucleotide and protein substrate. J Biol Chem. 2004; 279(14):13902-10. DOI: 10.1074/jbc.M309642200. View

2.
Moskovitz J . Roles of methionine suldfoxide reductases in antioxidant defense, protein regulation and survival. Curr Pharm Des. 2005; 11(11):1451-7. DOI: 10.2174/1381612053507846. View

3.
Wagner I, ARLT H, Van Dyck L, Langer T, Neupert W . Molecular chaperones cooperate with PIM1 protease in the degradation of misfolded proteins in mitochondria. EMBO J. 1994; 13(21):5135-45. PMC: 395461. DOI: 10.1002/j.1460-2075.1994.tb06843.x. View

4.
Wallace D . Diseases of the mitochondrial DNA. Annu Rev Biochem. 1992; 61:1175-212. DOI: 10.1146/annurev.bi.61.070192.005523. View

5.
Kwong J, Beal M, Manfredi G . The role of mitochondria in inherited neurodegenerative diseases. J Neurochem. 2006; 97(6):1659-75. DOI: 10.1111/j.1471-4159.2006.03990.x. View